Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $741.0.

  • Lemaitre Vascular's Gains from Investment Securities changed N/A to $741.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $741.0, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 4149.69% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Gains from Investment Securities stood at $741.0.
  • Lemaitre Vascular's Gains from Investment Securities' 5-year high stood at $6.0 million during Q4 2023, with a 5-year trough of -$2.4 million in Q4 2024.
  • Moreover, its 5-year median value for Gains from Investment Securities was $1660.0 (2023), whereas its average is $838669.8.
  • Per our database at Business Quant, Lemaitre Vascular's Gains from Investment Securities skyrocketed by 10379.36% in 2023 and then tumbled by 13949.35% in 2024.
  • Over the past 5 years, Lemaitre Vascular's Gains from Investment Securities (Quarter) stood at $3.5 million in 2021, then fell by 15.8% to $2.9 million in 2022, then skyrocketed by 103.79% to $6.0 million in 2023, then plummeted by 139.49% to -$2.4 million in 2024, then soared by 100.03% to $741.0 in 2025.
  • Its Gains from Investment Securities stands at $741.0 for Q3 2025, versus $741.0 for Q2 2025 and -$2.4 million for Q4 2024.